MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma Genetic Test
Test Name: MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma Genetic Test
Components: MTAP gene
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma NGS Genetic DNA Test gene MTAP
Test Details:
MTAP gene is a tumor suppressor gene that is frequently deleted in various cancers. Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) is a rare bone disorder characterized by narrowing of the medullary cavity of long bones and the presence of malignant fibrous histiocytoma.
NGS (Next Generation Sequencing) genetic test refers to a high-throughput DNA sequencing technology that allows simultaneous sequencing of multiple genes or the entire genome. In the context of DMS-MFH, NGS genetic testing can be used to identify mutations or alterations in the MTAP gene and other relevant genes associated with the condition.
By analyzing the DNA sequence of the patient’s genes, NGS can help in diagnosing DMS-MFH and identifying specific genetic alterations that may be responsible for the development of the disease. This information can be useful for determining prognosis, selecting appropriate treatment options, and potentially identifying targeted therapies for patients with DMS-MFH.
Test Name | MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MTAP Gene Diaphyseal medullary stenosis with malignant fibrous histiocytoma NGS Genetic DNA Test gene MTAP |
Test Details |
MTAP gene is a tumor suppressor gene that is frequently deleted in various cancers. Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) is a rare bone disorder characterized by narrowing of the medullary cavity of long bones and the presence of malignant fibrous histiocytoma. NGS (Next Generation Sequencing) genetic test refers to a high-throughput DNA sequencing technology that allows simultaneous sequencing of multiple genes or the entire genome. In the context of DMS-MFH, NGS genetic testing can be used to identify mutations or alterations in the MTAP gene and other relevant genes associated with the condition. By analyzing the DNA sequence of the patient’s genes, NGS can help in diagnosing DMS-MFH and identifying specific genetic alterations that may be responsible for the development of the disease. This information can be useful for determining prognosis, selecting appropriate treatment options, and potentially identifying targeted therapies for patients with DMS-MFH. |